Skip to main content

. 1988 Oct;58(4):500–501. doi: 10.1038/bjc.1988.249

A phase II study of carboplatin in adenocarcinoma of the oesophagus.

A Steel ¹, M H Cullen ¹, P W Robertson ¹, H R Matthews ¹

PMCID: PMC2246802 PMID: 3061440

500

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

GEHAN E. A. The determinatio of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent. J Chronic Dis. 1961 Apr;13:346–353. doi: 10.1016/0021-9681(61)90060-1. [DOI] [PubMed] [Google Scholar]
Miller A. B., Hoogstraten B., Staquet M., Winkler A. Reporting results of cancer treatment. Cancer. 1981 Jan 1;47(1):207–214. doi: 10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
Sternberg C., Kelsen D., Dukeman M., Leichman L., Heelan R. Carboplatin: a new platinum analog in the treatment of epidermoid carcinoma of the esophagus. Cancer Treat Rep. 1985 Nov;69(11):1305–1307. [PubMed] [Google Scholar]

ACTIONS

RESOURCES